NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Camlin Fine Sciences : Q4 2024 Financial Quarterly Report : YoY Sales Down 5.86 %, QoQ Up 4.1 %

May 21, 2024May 21, 2024| adminadmin| 0 Comments| 5:40 pm
Image is loading
Categories:

Share the post "Camlin Fine Sciences : Q4 2024 Financial Quarterly Report : YoY Sales Down 5.86 %, QoQ Up 4.1 %"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter: The company’s sales declined by -5.86 % over the year, substantial increase in net sales/revenue by 4.1 %.
  • Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 188 %. Marginal increase in other income during this quarter, up by 246.99%.
  • Profit over the Year and quarter: Challenges in sustaining profitability for Camlin Fine Sciences Ltd. Profit dropped by -2450.82 % Year to Year, Camlin Fine Sciences Ltd’s profitability increased by 472.84 % in this quarter.
  • EPS over the Year and quarter: EPS declined by -886.44 % Year to Year. EPS increased by 553.52 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of Camlin Fine Sciences Ltd”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 426.708 Cr Rs. 385.886 Cr Rs. 401.694 Cr + 4.1 % -5.86 %
Expenses Rs. 382.89 Cr Rs. 362.56 Cr Rs. 414.94 Cr + 14.45 % + 8.37 %
Operating Profit Rs. 43.82 Cr Rs. 23.33 Cr Rs. -13.25 Cr -156.79 % -130.24 %
OPM % 10.27 % 6.05 % -3.3 % -9.35 % -13.57 %
Other Income Rs. 2 Cr Rs. 1.66 Cr Rs. 5.76 Cr + 246.99 % + 188 %
Interest Rs. 9.78 Cr Rs. 14.14 Cr Rs. 16.17 Cr + 14.36 % + 65.34 %
Depreciation Rs. 17.93 Cr Rs. 20.58 Cr Rs. 20.05 Cr -2.58 % + 11.82 %
Profit before tax Rs. 18.11 Cr Rs. -9.73 Cr Rs. -43.71 Cr -349.23 % -341.36 %
Tax % 58.72 % -46.73 % -12.54 % + 34.19 % -71.26 %
Net Profit Rs. 3.48 Cr Rs. -14.28 Cr Rs. -81.79 Cr -472.76 % -2450.29 %
EPS in Rs Rs. 0.59 Rs. -0.71 Rs. -4.64 -553.52 % -886.44 %


Today, we’re looking at Camlin Fine Sciences Ltd’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -5.86 %. However, it did see a marginal increase of 4.1 % from the previous quarter. Expenses ticked up slightly by 14.45 % quarter-on-quarter, aligning with the annual rise of 8.37 %. Operating profit, while down -130.24 % compared to last year, faced a quarter-on-quarter dip of -156.79 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -13.57 %, but a shrinkage of -9.35 % sequentially. Other income rose by 246.99 % compared to the last quarter, despite an annual growth of 188 %. Interest expenses surged remarkably by 14.36 % from the previous quarter, yet the year-over-year increase remains at a moderate 65.34 %. Depreciation costs fell by -2.58 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 11.82 %. Profit before tax declined annually by -341.36 % but saw a reduction from the preceding quarter by -349.23 %.
Tax expenses as a percentage of profits decreased slightly by -71.26 % compared to last year, with a more notable quarter-on-quarter increase of 34.19 %. Net profit fell by -2450.29 % year-on-year but witnessed a -472.76 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -886.44 % but a quarterly fall of -553.52 %. In summary, Camlin Fine Sciences Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 426.708 Cr Rs. 385.886 Cr Rs. 401.694 Cr + 4.1 % -5.86 %
Expenses Rs. 382.89 Cr Rs. 362.56 Cr Rs. 414.94 Cr + 14.45 % + 8.37 %
Operating Profit Rs. 43.82 Cr Rs. 23.33 Cr Rs. -13.25 Cr -156.79 % -130.24 %
Net Profit Rs. 3.48 Cr Rs. -14.28 Cr Rs. -81.79 Cr -472.76 % -2450.29 %
EPS in Rs Rs. 0.59 Rs. -0.71 Rs. -4.64 -553.52 % -886.44 %


In reviewing Camlin Fine Sciences Ltd’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -5.86 % year-on-year, however, there was a minor increase of 4.1 % from the previous quarter. Expenses rose by 8.37 % compared to the previous year, with a 14.45 % increase quarter-on-quarter. Operating Profit dropped by -130.24 % annually, and saw a -156.79 % decrease from the last quarter.
Net Profit showed yearly decrease of -2450.29 %, and experienced a -472.76 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -886.44 % annually, however dipped by -553.52 % compared to the last quarter. In essence, while Camlin Fine Sciences Ltd faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Camlin Fine Sciences “]

Related Post